Mapping genetic interactions between growth-promoting mutations in yeast

Information

  • Research Project
  • 10151635
  • ApplicationId
    10151635
  • Core Project Number
    R01GM127420
  • Full Project Number
    5R01GM127420-04
  • Serial Number
    127420
  • FOA Number
    PA-16-160
  • Sub Project Id
  • Project Start Date
    5/1/2018 - 7 years ago
  • Project End Date
    4/30/2023 - 2 years ago
  • Program Officer Name
    KRASNEWICH, DONNA M
  • Budget Start Date
    5/1/2021 - 4 years ago
  • Budget End Date
    4/30/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    04
  • Suffix
  • Award Notice Date
    4/23/2021 - 4 years ago
Organizations

Mapping genetic interactions between growth-promoting mutations in yeast

A global understanding of genetic interaction networks, and how network perturbations affect cellular function, is crucial to preventing and treating human disease. Currently there is a fundamental gap in our understanding of these networks. Most of our knowledge of genetic interactions comes from the systematic analysis of double deletion (or knockdown) mutants, primarily in the yeast Saccharomyces cerevisiae. However, the reality is that loss-of-function mutations are rarely beneficial and account for less than 5% of the known natural genetic variation. Continued existence of this gap is a significant problem because many biomedically-important interactions are likely missed by current methods. The proposed research will identify genetic interactions involving alteration-of-function variants, variants of essential genes, and higher-order interactions using a novel ?Evolve-and-Map? approach, which combines experimental evolution and quantitative-trait locus mapping. The rationale for this approach is that experimental evolution efficiently selects for perturbations to the genetic interaction network that promote rapid growth, and that the genetic variants isolated in this way will be comparable to the natural genetic variants underlying complex traits in other organisms, including humans. AIM 1 will leverage the power of evolutionary ?replay? experiments to identify a local network of genetic interactions between cell polarity genes and cell cycle genes. These interactions are strongly supported by preliminary laboratory evolution experiments, but are largely absent from the double-deletion genetic interaction network. AIM 2 will extend this analysis genome-wide, producing the largest data set to date on the genetic interactions between variants that arose in the context of experimental evolution. Thousands of double-barcoded segregants will be generated from crosses between evolved lines and their ancestor or between pairs of evolved lines. Each segregant will be genotyped by low-coverage sequencing and its fitness will be measured using a highly-multiplexed barcode-sequencing-based assay that is capable of measuring the fitness of thousands of segregants en masse. These data will be used to detect additive effects as well as pairwise and three-way genetic interactions. Since these mapping populations contain far fewer variants than is typical in a genome-wide scan, the power of this method to detect genetic interactions is very high. AIM 3 will determine the extent to which these genetic interactions persist across environments, including different carbon and nitrogen sources, inhibitory concentrations of antifungals, and non-optimal temperatures. This will add an important new dimension to genetic interaction networks. Overall the results obtained from this work will test the ability of the double-deletion genetic interaction network to predict interactions between growth-promoting variants, and will advance our understanding of genetic interaction networks and the evolution of complex traits.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    210000
  • Indirect Cost Amount
    120629
  • Total Cost
    330629
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIGMS:330629\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    GCAT
  • Study Section Name
    Genomics, Computational Biology and Technology Study Section
  • Organization Name
    LEHIGH UNIVERSITY
  • Organization Department
    BIOLOGY
  • Organization DUNS
    808264444
  • Organization City
    BETHLEHEM
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    18015
  • Organization District
    UNITED STATES